You are here

Article info

Article menu
Download PDFPDF
Review
ROCK inhibitors for the treatment of ocular diseases

Authors

  • Ramin Nourinia Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Shintaro Nakao Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Souska Zandi Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA Swiss Eye Institute and Clinic for Vitreoretinal Diseases, Berner Augenklinik am Lindenhofspital, Bern, Switzerland PubMed articlesGoogle scholar articles
  • Sare Safi Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  • Ali Hafezi-Moghadam Center for Excellence in Functional and Molecular Imaging, Brigham and Women’s Hospital, Harvard University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Hamid Ahmadieh Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hamid Ahmadieh, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran 16666, Iran; hahmadieh{at}hotmail.com
View Full Text

Citation

Nourinia R, Nakao S, Zandi S, et al
ROCK inhibitors for the treatment of ocular diseases
British Journal of Ophthalmology 2018;102:1-5.

Publication history

  • Received February 22, 2017
  • Revised July 10, 2017
  • Accepted July 22, 2017
  • First published August 9, 2017.
Online issue publication 
August 03, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.